“Comparison of Safety and Efficacy Between Dabigatran and Rivaroxaban in Nonvalvular Atrial Fibrillation in Tertiary Level Hospital”. University Heart Journal, vol. 18, no. 1, Jan. 2022, pp. 10-13, https://doi.org/10.3329/uhj.v18i1.57874.